Liga Sure Versus Conventional Suture Ligature for Decrease Blood Loss During Abdominal Hysterectomy

January 6, 2020 updated by: hany farouk, Aswan University Hospital

Liga Sure Versus Conventional Suture Ligature for Decrease Blood Loss During Abdominal Hysterectomy: Randomized Controlled Trial

Liga Sure represents a novel principle for hemostatic sealing of vessel-containing tissue based on feedback-programmed dosage of bipolar diathermy.(5) According to marketing of the device, Liga Sure has the potential to replace the use of conventional suture ligature within a broad range of surgical procedures, also including removal of the uterus. While the use of Liga Sure has been critically assessed for a range of procedures such as hemorrhoidectomy, splenectomy, bile duct, urological and gastric operations,(6-12) a similar scientific evaluation of its suitability for abdominal removal of the uterus is lacking in the literature. The most promising aspect of Liga Sure in hysterectomy is the potential shorter operation time and decrease blood loss. Because removal of the uterus traditionally is the most frequently performed major gynecological operation,(13) the introduction of a time-sparing new technique could have significant impact on resource consumption.

The aim of the study:

we aimed at evaluating the use of Liga Sure compared with conventional suture ligature during abdominal hysterectomy, in a prospective randomized controlled trial with special emphasis on the safety, the duration of the procedure and the amount of blood loss.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Hysterectomy represents the second most performed surgery in gynecology after the Cesarean Section. Worldwide most of the hysterectomies are performed abdominally. (1) One in 9 women will undergo a hysterectomy in their lifetime. (1) Surgical blood loss of more than 1000 mL or blood loss that requires a blood transfusion usually defines intraoperative hemorrhage. Intraoperative hemorrhage has been reported in 1% to 2% of hysterectomy studies. (2) As with any surgical treatment, complications affect the outcomes of hysterectomy. Hemorrhage, which is the most frequent and critical complication, often occurs during surgery. Data from The Danish Hysterectomy and Hysteroscopy Database (DHHD) has revealed a relatively high complication rate of 16-18% from 1998 to 2006, of which perioperative bleeding complications represent the most common cause.(3 )From 2004 to 2006, 6-8% of all women undergoing benign hysterectomy in Denmark experienced a bleeding complication .(4 ) Therefore, adequate hemostatic techniques are essential during abdominal hysterectomy. Currently, surgical hemostasis can be secured by a variety of methods, including mechanical sutures (or clamping), electric coagulation, ultrasonically activated scalpel or drugs. (4)

Liga Sure represents a novel principle for hemostatic sealing of vessel-containing tissue based on feedback-programmed dosage of bipolar diathermy.(5) According to marketing of the device, Liga Sure has the potential to replace the use of conventional suture ligature within a broad range of surgical procedures, also including removal of the uterus. While the use of Liga Sure has been critically assessed for a range of procedures such as hemorrhoidectomy, splenectomy, bile duct, urological and gastric operations,(6-12) a similar scientific evaluation of its suitability for abdominal removal of the uterus is lacking in the literature. The most promising aspect of Liga Sure in hysterectomy is the potential shorter operation time and decrease blood loss. Because removal of the uterus traditionally is the most frequently performed major gynecological operation,(13) the introduction of a time-sparing new technique could have significant impact on resource consumption.

The aim of the study:

we aimed at evaluating the use of Liga Sure compared with conventional suture ligature during abdominal hysterectomy, in a prospective randomized controlled trial with special emphasis on the safety, the duration of the procedure and the amount of blood loss.

Materials and Methods After obtaining ethics committee approval and patient consent, we will randomize patients about to undergo elective abdominal hysterectomy, between the use of Liga Sure and conventional suture ligature during the operation. Patients who were admitted for non-acute planned abdominal total or subtotal hysterectomy were eligible. Two experienced lecturer gynecologists performed the operations. 60 patients for each of the tow operators were block-randomized. The treatment options, 30 of each in each randomization block, were first concealed in envelopes. Thereafter, the sequence was generated using computer-generated random number lists. The 60 projected patients will include and will be randomized between December 2017 and December 2019. The following pre- and intra-operative parameters will be registered: the indication for the operation, the type of incision, procedures in addition to the hysterectomy, the duration of the operation, the blood loss and the use of intra-operative blood transfusions. When Liga Sure was used, the eventual number of its replacements by suture ligature due to unsuccessful vessel sealing was registered. During the first 30 post-operative days, the following parameters were registered: all types of re-operations, the use of blood transfusion, the occurrence of fever above 38°C, all types of infections, deep vein thrombosis and the length of the post-operative hospital stay.

Measurement of Blood Loss Blood loss well be estimated by a combination of direct measurement and gravimetric method (14). The direct measurement well performed by collecting most of the lost blood into a suction bottle using a suction apparatus. Care was taken to collect most of (if not all) the amniotic fluid in a separate suction bottle. The gravimetric method well used to estimate the amount of blood loss in the surgical towels. The dry surgical towels (40 by 40 cm) were weighed before surgery. Intraoperatively, the towels were used to dry up all the blood in the surgical field then these towels were collected into a sterile metallic bowl which was weighed empty before surgery. When 5 soaked towels are collected in the bowl, the bowl with the collected soaked towels are handled to the circulating nurse to weigh it by a highly accurate digital balance and then calculate the amount of blood loss in the towels by the following formula: amount of blood loss in the soaked towels (in ml) = weight of the metallic bowl with the collected soaked towels in it (in gm)- [weight of the empty bowel (in gm) + weight of the towels before surgery (in gm)]. The collected blood in the suction bottle well added to the total calculated amount of blood loss in the towels.

The primary outcomes are the total blood loss during and after hysterectomy. the secondary outcome is another surgical maneuver to decrease blood loss (need of suturing in the Liga sur arm), operative time ,any complication Statistical Analysis; Continuous variables were presented as mean ± standard deviation, while categorical variables were presented as frequencies and percentages. The IBM (SPSS) Statistics, version 20.0, for Windows was used for statistical analysis. P values ≤0.05 were considered statistically significant.

Study Type

Interventional

Enrollment (Actual)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Aswan, Egypt, 81528
        • AswanUH

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 60 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • patient prepared for an elective benign hysterectomy

Exclusion Criteria:

  1. Patients with a cardiac, hepatic, renal or thromboembolic disease.
  2. patients with pelvic endometriosis and adnexal mass.
  3. patients with endometrial or cervical cancer
  4. radical hysterectomy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: conventional suture ligature
use of conventional sutures for hysterectomy
we use Liga-sure device for hysterectomy
ACTIVE_COMPARATOR: Liga Sure
use of conventional sutures plus use of Liga-sure for hysterectomy
we use Liga-sure device for hysterectomy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
decrease blood loss during hysterectomy
Time Frame: intra-operative
Blood loss well be estimated by a combination of direct measurement and gravimetric method
intra-operative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
need for blood transfusion,
Time Frame: intraoperative
number RBC unit trasfused
intraoperative
post operative HB
Time Frame: 24 hour post operative
measure HB pos operative
24 hour post operative
operative time
Time Frame: intra operative
time of operation
intra operative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 1, 2018

Primary Completion (ACTUAL)

September 30, 2019

Study Completion (ACTUAL)

December 30, 2019

Study Registration Dates

First Submitted

April 7, 2018

First Submitted That Met QC Criteria

April 12, 2018

First Posted (ACTUAL)

April 23, 2018

Study Record Updates

Last Update Posted (ACTUAL)

January 7, 2020

Last Update Submitted That Met QC Criteria

January 6, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • aswu/202/18

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Decrease Blood Loss During Abdominal Hysterectomy

Clinical Trials on conventional suture

Subscribe